New Mexico governor calls for criminal probe of DEA allowing fentanyl shipments to hit streets
New Mexico Governor Calls for DEA Criminal Probe Over Fentanyl Crisis
New Mexico governor calls for criminal - New Mexico Governor Michelle Lujan Grisham has demanded a criminal probe into the Drug Enforcement Administration (DEA) for its role in allowing hundreds of thousands of fentanyl pills to flow into the state over two years. This action follows an Associated Press (AP) report revealing that federal agents systematically permitted significant fentanyl shipments, rather than seizing them immediately, as they prioritized larger trafficking networks. The governor’s move highlights the growing frustration with a system that has neglected the immediate dangers faced by New Mexico communities in the ongoing opioid epidemic.
A Bold Demand for Accountability
The AP investigation detailed how DEA agents in New Mexico between 2023 and 2025 allowed fentanyl shipments to pass through the state, bypassing standard protocols to intercept the drug. Grisham’s call for a criminal probe marks a rare instance of a state leader challenging federal enforcement, emphasizing that the DEA’s decisions had severe consequences for public safety. She argued that the agency’s inaction not only endangered lives but also undermined the legal framework designed to protect communities from opioid-related deaths.
“There are no words to describe how reckless and dangerous these decisions were,” Lujan Grisham stated in a public statement. “Make no mistake: the DEA knew people would die if these pills made it into New Mexico communities, and the agency let it happen anyway.”
Grisham’s request has shifted the focus from drug enforcement tactics to the accountability of federal agents themselves. The state’s legal standards now serve as a benchmark for the DEA’s actions, with the governor urging the attorney general to determine whether the agency’s decisions constituted a criminal breach. This move underscores her commitment to holding federal entities responsible for the ongoing fentanyl crisis that has ravaged New Mexico’s population.
Federal Justifications Under Scrutiny
The DEA has defended its strategy, stating that intercepting every shipment was impractical during the investigation. According to the agency, its decisions aligned with departmental guidelines and were lawful. However, critics argue that this justification ignored established protocols to safeguard the public, particularly in a state where fentanyl has become the primary cause of fatal overdoses. The DEA’s approach has been criticized as a calculated risk that prioritized broader investigations over immediate community protection.
A DEA whistleblower, David Howell, has drawn attention to the unseized fentanyl pills, filing a complaint that has now been examined by congressional staff. His case has also garnered support from Empower Oversight, a nonprofit organization that advocates for whistleblowers. The group has urged the Senate Judiciary Committee and the Justice Department’s Office of Inspector General to further investigate the allegations, linking the DEA’s strategy to a broader pattern of neglect in New Mexico.
While the DEA maintains its actions were justified, critics like current and former agents have raised concerns about the agency’s prioritization of larger networks over the immediate risks posed by smaller shipments. The "One Pill Can Kill" campaign, which emphasizes the lethal potential of fentanyl, appears to be at odds with the DEA’s recent decisions, fueling accusations of a deliberate compromise in public safety efforts.
State-Level Impact and Overdose Trends
New Mexico’s overdose statistics have intensified the governor’s call for a criminal probe. Despite a 14% nationwide decline in fatal overdoses last year, the state reported a 21% surge, underscoring the severity of the crisis. Grisham asserted that “New Mexican lives are not the federal government’s cost of doing business,” emphasizing the need for stricter enforcement and accountability. The AP report cited specific cases, including a 2023 delivery of 74,000 fentanyl pills to a mobile home park in Albuquerque, which federal agents surveilled but did not intercept.
The DEA’s handling of fentanyl in New Mexico has been a focal point of public outcry. Victims’ groups have criticized the agency for contradicting its own messaging about the drug’s dangers. Michael Glownia, a father who lost his daughter to a fentanyl overdose in 2023, expressed deep disappointment, stating, “The DEA’s failure to stop these shipments in New Mexico is a criminal act that has cost countless lives.” This sentiment reflects the broader frustration among residents, who see the DEA’s inaction as a direct threat to their health and safety.
Political Response and Public Outcry
Senator Bernie Moreno, a Republican from Ohio, has publicly condemned the DEA’s inaction, calling the revelations “a scandal of the highest order.” He pledged to investigate how many lives were lost due to the agency’s delayed response to the fentanyl crisis. Meanwhile, New Mexico Governor Lujan Grisham’s demand for a criminal probe has intensified the debate over federal drug enforcement priorities, with critics arguing that the DEA’s approach has created a dangerous precedent in the fight against opioids.
The governor’s call for a criminal probe has gained traction amid rising concerns about the DEA’s role in the crisis. By linking the agency’s decisions to criminal liability, Grisham has amplified the urgency of the situation. As the fentanyl epidemic continues to claim lives, the demand for accountability grows, with New Mexico at the center of a national conversation about the effectiveness of federal drug policies. This development could set a new standard for how drug enforcement agencies are held responsible for their actions in vulnerable communities.